Monic Stuart
Hoofd Techniek/Wetenschap/O&O bij MARKER THERAPEUTICS, INC.
Profiel
Monic Stuart is currently the Chief Medical Officer at Marker Therapeutics, Inc. Prior to this, he held the position of Senior Medical Director at Genentech, Inc. from 2004 to 2009.
He then served as the Vice President-Clinical Development at Geron Corp.
from 2011 to 2012.
Dr. Stuart completed his graduate degree at The Johns Hopkins University and holds undergraduate and doctorate degrees from the University of North Carolina at Chapel Hill.
Actieve functies van Monic Stuart
| Bedrijven | Functie | Begin |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-05-2023 |
Eerdere bekende functies van Monic Stuart
| Bedrijven | Functie | Einde |
|---|---|---|
| GERON CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-02-2012 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
Opleiding van Monic Stuart
| University of North Carolina at Chapel Hill | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |